For referring physicians
Consider apheresis despite maximally tolerated lipid-lowering therapy for:
- Homozygous FH
- Heterozygous FH with LDL-C ≥300 mg/dL, or ≥100 mg/dL with coronary disease
- Lp(a) ≥60 mg/dL with LDL-C ≥100 mg/dL and coronary or peripheral artery disease
We handle the evaluation, prior authorization and ongoing treatment, and send you notes after every visit.
Refer online · Fax 716-249-6750 · Questions: 716-800-2572
Criteria and insurance coverage vary. Call to discuss a patient.